LightIntegra Technology got its start in the Canadian Blood Services research labs through the efforts of research scientist Dr. Elisabeth Maurer. Her years of research on platelet function lead to a breakthrough discovery about the temperature response of platelets. Dr. Maurer recognized the opportunity to use this discovery coupled with recent advances in laser and optics technology to address a market need to provide a safe, quick and simple diagnostic test for platelet quality and function. The company was incorporated in November 2008 in order to commercialize the ThromboLUXTM technology. The company successfully closed its first round of financing in July 2009 and is currently working to develop the first commercial version of the ThromboLUXTM instrument with the intention to market the device by the end of 2010.